Targeting FSTL1-DIP2A axis for treating osteosarcoma

被引：0
|
作者：
Ogiwara, Yamato [1 ]
Nakagawa, Makoto [2 ]
Nakatani, Fumihiko [3 ]
Hirose, Takeshi [3 ]
Yoshida, Akihiko [4 ]
Kudo-Saito, Chie [1 ]
机构：
[1] Natl Canc Ctr, Res Inst, Tokyo, Japan
[2] Natl Canc Ctr, Res Inst, Hematol Malig, Tokyo, Japan
[3] Natl Canc Ctr, Muscul Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Pathol, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1005
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [1] Metastasis suppression and enhancement of anti-tumour immunity by targeting the FSTL1-DIP2A axis
    Sundaram, Gopinath M.
    Quah, Shan
    Sampath, Prabha
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S149 - S151
  • [2] Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity
    Kudo-Saito, Chie
    Ishida, Akiko
    Shouya, Yuji
    Teramoto, Koji
    Igarashi, Tomoyuki
    Kon, Ryoko
    Saito, Kenji
    Awada, Chihiro
    Ogiwara, Yamato
    Toyoura, Masayoshi
    CELL REPORTS, 2018, 24 (07): : 1790 - 1801
  • [3] DIP2A Functions as a FSTL1 Receptor
    Ouchi, Noriyuki
    Asaumi, Yasuhide
    Ohashi, Koji
    Higuchi, Akiko
    Sono-Romanelli, Saki
    Oshima, Yuichi
    Walsh, Kenneth
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (10) : 7127 - 7134
  • [4] Targeting the β -catenin signaling axis in osteosarcoma
    Curcic, Marina
    Gaikwad, Shreyas
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Blocking FSTL1 ameliorates immunity against osteosarcoma
    Kudo-Saito, Chie
    Ogiwara, Yamato
    Aoki, Kazunori
    CANCER RESEARCH, 2017, 77
  • [6] Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
    Xin Wang
    Ge Qin
    Xiaoting Liang
    Wen Wang
    Zhuo Wang
    Dan Liao
    Li Zhong
    Ruhua Zhang
    Yi-Xin Zeng
    Yuanzhong Wu
    Tiebang Kang
    Nature Communications, 11
  • [7] Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
    Wang, Xin
    Qin, Ge
    Liang, Xiaoting
    Wang, Wen
    Wang, Zhuo
    Liao, Dan
    Zhong, Li
    Zhang, Ruhua
    Zeng, Yi-Xin
    Wu, Yuanzhong
    Kang, Tiebang
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [8] Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma
    Ogiwara, Yamato
    Nakagawa, Makoto
    Nakatani, Fumihiko
    Uemura, Yasushi
    Zhang, Rong
    Kudo-Saito, Chie
    CANCER LETTERS, 2022, 537
  • [9] Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
    Er Nie
    Faan Miao
    Xin Jin
    Weining Wu
    Xu Zhou
    Ailiang Zeng
    Tianfu Yu
    Tongle Zhi
    Zhumei Shi
    Yingyi Wang
    Junxia Zhang
    Ning Liu
    Yongping You
    Oncogene, 2019, 38 : 2706 - 2721
  • [10] Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
    Nie, Er
    Miao, Faan
    Jin, Xin
    Wu, Weining
    Zhou, Xu
    Zeng, Ailiang
    Yu, Tianfu
    Zhi, Tongle
    Shi, Zhumei
    Wang, Yingyi
    Zhang, Junxia
    Liu, Ning
    You, Yongping
    ONCOGENE, 2019, 38 (15) : 2706 - 2721
12345